Omega-3 fatty acids in the treatment of affective disorders: An overview of the literature;Omega-3-vetzuren bij de behandeling van stemmingsstoornissen: Een literatuuroverzicht

Tijdschrift voor Psychiatrie

Volumn 49, Issue 2, 2007, Pages 85-94

  Van Strater, A C P ^a,c   Bouvy, P F ^b  

^a GGZ Duin en Bollenstreek   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NONE   (Netherlands)

Author keywords

Bipolar disorder; Depressive disorder; Fatty acids; Fish oils; Mood disorders; Omega 3

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

BIBLIOGRAPHIC DATABASE; DRUG EFFICACY; FATTY ACID ANALYSIS; HUMAN; MEDICAL LITERATURE; MOOD DISORDER; PUERPERAL DEPRESSION; REVIEW;

EVIDENCE-BASED MEDICINE; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; MOOD DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 33847110227     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Adams, P.B., Lawson S., Sanigorski A., et al. (1996). Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids, 31(Suppl.),S157-S161.
2. Browne, J.C., Scott, K.M., & Silvers, K.M. (2006). Fish consumption in pregnancy and omega-3 status after birth are not associated with postnatal depression. Journal of Affective Disorders, 90, 131-139.
3. Bucher, H.C., Hengstler, P., Schindler, C., et al. (2002). N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. The American Journal of Medicine, 112, 2518-304.
4. Castanon, N., Leonard, B.E., Neveu, P.J., et al. (2002). Effects of antidepressants on cytokine production and actions. Brain, Behavior, and Immunity, 16, 569-574.
5. Chiu, C.C., Huang, S.Y., Chen, C.C., et al. (2005). Omega-3 fatty acids are more beneficial in the depressive phase than in the manic phase in patients with bipolar I disorder. The Journal of Clinical Psychiatry, 66, 1613-1614.
6. Chiu, C.C., Huang, S.Y., Shen, W.W., et al. (20033). Omega-3 fatty acids for depression in pregnancy. The American Journal of Psychiatry, 160, 385.
7. Chiu, C.C., Huang, S.Y., Su, K.P., et al. (2003b). Polyunsaturated fatty acid deficit in patients with bipolar mania. European Neuropsychopharmacology, 13, 99-103.
8. Cott, J., & Hibbeln, J.R. (2001). Lack of seasonal mood change in Icelanders. The American Joumal of Psychiatry, 158, 328.
9. Dantzer, R. (2001). Cytokine-induced sickness behavior: where do we stand? Brain, Behavior, and Immunity, 15, 7-24.
10. Edwards, R., Peet, M., Shay, J., et al. (1998). Omega-3 Polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. Journal of Affective Disorders, 48, 149-155.
11. Ellis, F.R., & Sanders, T.A. (1977). Long chain polyunsaturated fatty acids in endogenous depression. Journal of Neurology, Neurosurgery, and Psychiatry, 40, 168-169.
12. Fehily, A.M.A., Bowey, O.A.M., Ellis, F.R., et al. (1981). Plasma and erythrocyte membrane long chain polyunsaturated fatty acids in endogenous depression. Neurochemistry International, 3, 37-42.
13. Frangou, S., Lewis, M., & McCrone, P. (2006). Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. The British Journal of Psychiatry, 188, 46-50.
14. Frasure-Smith, N., & Lespérance, F. (2005). Reflections on depression as a cardiac risk factor. Psychosomatic Medicine, 67(Suppl. 1), S19-S25.
15. Frasure-Smith, N., Lespérance, F., & Julien, P. (2004). Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biological Psychiatry, 55, 891-896.
16. Freeman, M.P., Hibbeln, J.R., Wisner, K.L., et al. (2006). Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatrica Scandinavica, 113, 31-35.
17. GAP (Group for the Advancement of Psychiatry) committee on Psychopharmacology. (2003, September). Omega-3 fatty acids and psychiatric disorders. www.groupadpsych.org/files/2003/omega3.pdf/download.
18. Gesch, C.B., Hammond, S.M., Hampson, S.E., et al. (2002). Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners. Randomised, placebo-controlled trial. The British Journal of Psychiatry, 181, 22-28.
19. Hakkarainen, R., Partonen, T., Haukka, J., et al. (2004). Is low dietary intake of omega-3 fatty acids associated with depression? The American Journal of Psychiarry, 161, 567-569.
20. Harris, W.S., Ginsberg, H.N., Arunakul, N., et al. (1997). Safety and efficacy of Omacor in severe hypertriglyceridemia. Journal of Cardiovascular Risk, 4, 385-391.
21. Hibbeln, J.R. (1998). Fish consumption and major depression. Lancet, 351, 1213.
22. Hibbeln, J.R. (2002). Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. Journal of Affective Disorders, 69, 15-29.
23. Horrobin, D.F. (2002). A new category of psychotropic drugs: neuroactive lipids as exemplified by ethyl eicosapentaenoate (E-E). Progress in Drug Research, 59, 171-199.
24. Jacka, F.N., Pasco, J.A., Henry, M.J., et al. (2004). Dietary omega-3 fatty acids and depression in a community sample. Nutritional Neuroscience, 7, 101-106.
25. Keck, P.E., Jr., McElroy, S.L., Freeman, M.P., et al. (2003a). Randomized, placebo-controlled trial of eicosapentaenoic acid in bipolar depression (Abstract). Bipolar Disorders, 5(Suppl. 1), S58.
26. Keck, P.E., Jr., McElroy, S.L., Freeman, M.P., et al. (2003b). Randomized, placebo-controlled trial of eicosapentaenoic acid in rapid cycling bipolar disorder (Abstract). Bipolar Disorders, 5(Suppl. 1), S58.
27. Kinrys, G. (2000). Hypomania associated with omega 3 fatty acids. Archives of Central Psychiatry, 57, 715-716.
28. Kobayakawa, M., Yamawaki, S., Hamazaki, K., et al. (2005). Levels of omega-3 fatty acid in serum phospholipids and depression in patients with lung cancer. British Journal of Cancer, 93, 1329-1333.
29. Kronfol, Z., & Remick, D.G. (2000). Cytokines and the brain: implications for clinical psychiatry. The Americanjoumal of Psychiatry, 157, 683-694.
30. Lake, J. (2002, October). Omega-3 fatty acids: theory, clinical trials and safety issues. Psychiatric Times, XIX (issue 10). www.psychiatric-times.com/article/print.jhtml?articleID=175802252
31. Leonard, B.E. (2001). The immune system, depression and the action of antidepressants. Progressions in Neuro-Psychopharmacology & Biological Psychiatry, 25, 767-780.
32. Llorente, A.M., Jensen, C.L., Voigt, R.G., et al. (2003). Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. American Journal of Obstetrics and Gynecology, 188, 1348-1353.
33. Logan, A.C. (2004). Omega-3 fatty acids and major depression: a primer for the mental health professional. Lipids in Health and Disease, 3, 25.
34. Maes, M., Christophe, A., Delanghe, J., et al. (1999). Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Research, 85, 275-291.
35. Macs, M., Smith, R., Christophe, A., et al. (1996). Fatty acid composition in major depression: decreased omega3 fractions in cholesteryl esters and increased C20:4omega6/C20:5omega3 ratio in cholesteryl esters and phospholipids. Journal of Affective Disorders, 38, 35-46.
36. Mamalakis, G., Kiriakakis, M., Tsibinos, G., et al. (2004). Depression and adipose polyunsaturated fatty acids in an adolescent group. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 71, 289-294.
37. Mamalakis, G., Tornaritis, M., & Kafatos, A. (2002). Depression and adipose essential polyunsaturated fatty acids. Prostaglandins, Leukotrieries, and Essential Fatty Acids, 67, 311-318.
38. Marangell, L.B., Martinez, J.M., Zboyan, H.A., Chong, H., et al. (2004). Omega-3 fatty acids for the prevention of postpartum depression: negative data from a preliminary, open-label pilot study. Depression and Anxiety, 19, 20-23.
39. Marangell, L.B., Martinez, J.M., Zboyan, H.A., Kertz, B., et al. (2003). A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. The American Journal of Psychiatry, 160, 996-998.
40. Murck, H., Song, C., Horrobin, D.F., et al. (2004). Ethyl-eicosapentaenoate and dexamethasone resistance in therapy-refractory depression. The International Journal of Neuropsychopharmacology, 7, 341-349.
41. Nemets, B., Stahl, Z., & Belmaker, R.H. (2002). Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. The American Journal of Psychiatry, 159, 477-479.
42. Noaghiul, S., & Hibbeln, J.R. (2003). Cross-national comparisons of seafood consumption and rates of bipolar disorders. The American Journal of Psychiatry, 160, 2222-2227.
43. Osher, Y., Bersudsky, Y., & Belmaker, R.H. (2005). Omega-3 eicosapentaenoic acid in bipolar depression: report of a small open-label study. The Journal of Clinical Psychiatry, 66, 726-729.
44. Otto, S.J., de Groot, R.H., & Hornstra, G. (2003). Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 69, 237-243.
45. Peet, M. (2004). International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis. The British Journal of Psychiatry, 184, 404-408.
46. Peet, M., & Edwards, R.W. (1997). Lipids, depression and physical diseases. Current Opinion in Psychiatry, 10, 477-480.
47. Peet, M., & Horrobin, D.F. (2002). A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Archives of General Psychiatry, 59, 913-919.
48. Peet, M., Murphy, B., Shay, J., et al. (1998). Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biological Psychiatry, 43, 315-319.
49. Peet, M., & Stokes, C. (2005). Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs, 65, 1051-1059.
50. Post, R.M., Leverich, G.S., Altshuler, L.L., et al. (2003). An overview of recent findings of the Stanley Foundation Bipolar Netwotk (Part I). Bipolar Disorders, 5, 310-319.
51. Puri, B.K., & Boyd, H. (2004). The natural way to beat depression. The groundbreaking discovery of EPA to change your life. London: Hodder & Stoughton.
52. Puri, B.K., Counsell, S.J., Hamilton, G., et al. (2001). Eicosapentaenoic acid in treatment-resistant depression associated with symptom remission, structural brain changes and reduced neuronal phospholipid turnover. International Journal of Clinical Practice, 55, 560-563.
53. Ranjekar, P.K., Hinge, A., Hegde, M.V., et al. (2003). Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Research, 121, 109-122.
54. Rudin, D.O. (1981). The major psychoses and neuroses as omega-3 essential fatty acid deficiency syndrome: substrate pellagra. Biological Psychiatry, 16, 837-850.
55. Rugulies, R. (2002). Depression as a predictor for coronary heart disease. A review and meta-analysis. American Journal of Preventive Medicine, 23, 51-61.
56. Ruxton, C.H.S., Calder, P.C., Reed, S.C., et al. (2005). The impact of long-chain n-3 polyunsaturated fatty acids on human health. Nutrition Research Reviews, 18, 113-129.
57. Schins, A., Honig, A., & Maes, M. (2001). Poly-unsaturated fatty acids: the missing link between cardiac events and depression. Acta Neuropsychiatrica, 13, 38-45.
58. Servan-Schreiber, D. (2003). Uw brein als medicijn. Utrecht/Antwerpen: Kosmos-Z&K Uitgevers.
59. Severus, W.E., Littman, A.B., & Stoll, A.L. (2001). Omega-3 fatty acids, homocysteine, and the increased risk of cardiovascular mortality in major depressive disorder. Harvard Review of Psychiatry, 9, 280-293.
60. Silvers, K.M., & Scott, K.M. (2002). Fish consumption and self-reported physical and mental health status. Public Health Nutrition, 5, 427-431.
61. Silvers, K.M., Woolley, C.C., Hamilton, F.C., et al. (2005). Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression. Prostaglondins, Leukotrienes, and Essential Fatty Acids, 72, 211-218.
62. Simopoulos, A.P. (1999). Essential fatty acids in health and chronic disease. The American Journal of Clinical Nutrition, 70(Suppl. 3), 560S-569S.
63. Simopoulos, A.P., & Robinson, J. (1999). The omega diet: the life saving nutritional program based on the diet of the island of Crete. New York: Harper Collins.
64. Smith, R.S. (1991). The macrophage theory of depression. Medical Hypotheses, 35, 298-306.
65. Sontrop, J., & Campbell, M.K. (2006). Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique. Preventive Medicine, 42, 4-13.
66. Stoll, A.L. (2002). The omega-3 connection. The groundbreaking antidepression diet and brain program. New York: Simon and Schuster.
67. Stoll, A.L., Damico, K.E., Daly, B.P., et al. (2001). Methodological considerations in clinical studies of omega 3 fatty acids in major depression and bipolar disorder. World Review of Nutrition and Dietetics, 88, 58-67.
68. Stoll, A.L., Severus, W.E., Freeman, M.P., et al. (1999). Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Archives of General Psychiatry, 56, 407-412.
69. Su, K.P., Huang, S.Y., Chiu, C.C., et al. (2003). Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. European Neuropsychopharmacology, 13, 267-271.
70. Suzuki, S., Akechi, T., Kobayashi, M., et al. (2004). Daily omega-3 fatty acid intake and depression in Japanese patients with newly diagnosed lung cancer. British Journal of Cancer, 90, 787-793.
71. Tanskanen, A., Hibbeln, J.R., Tuomilehto, J., et al. (2001). Fish consumption and depressive symptoms in the general population in Finland. Psychiatric Services, 52, 529-531.
72. Tiemeier, H., van Tuijl, H.R., Hofman, A., et al. (2003). Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. The American Journal of Clinical Nutrition, 78, 40-46.
73. Timonen, M., Horrobin, D., Jokelainen, J., et al. (2004). Fish consumption and depression: the Northern Finland 1966 birth cohort study. Journal of Affective Disorders, 82, 447-452.
74. Vriese, S.R. de, Christophe, A.B., & Maes, M. (2003). Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. Life Sciences, 73, 3181-3187.
75. Weinrieb, R.M., Auriacombe, M., Lynch, K.G., et al. (2005). Selective serotonin re-uptake inhibitors and the risk of bleeding. Expert Opinion on Drug Safety, 4, 337-344.
76. Zanarini, M.C., & Frankenburg, F.R. (2003). Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. The American Journal of Psychiatry, 160, 167-169.